Open Accesscomparative study to evaluate the efficacy of panchtikta ghrita and bisphosphonate in the management of postmenopausal osteoporosis (asthikshaya)
Author(s) -
Renuka Gajendra,
Vaishali Kuchewar
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns2.5072
Subject(s) - osteoporosis , medicine , bisphosphonate , menopause , postmenopausal osteoporosis , bone remodeling , urology , bone mineral
Asthikshaya is a disorder related to bone degeneration. It is similar to osteoporosis. A disturbance in bone remodeling is the underlying mechanism for decrease in normal bone density. Osteoporosis is caused due to low bone mass, and micro architectural breakdown of bone tissue. In India, Osteoporosis is an emerging public health problem with increasing numbers of elderly. Women are more prone as compared to men. Risk of Osteoporosis even increases at the stage of menopause, which is physiological transition period of hormonal imbalance. Aims and objectives: To compare the efficacy of Panchtikta Ghrita and Bisphosphonate in the management of Postmenopausal osteoporosis (Asthikshaya). Methodology: For proposed study,Postmenopausal womenwill be assessed for BMD by organizing special camp for assessment of BMD, Recruitment of women having T‟ score -2.5 to -1 subjects will be randomly divided into two groups. Group A will be given Panchtikta Ghritain the dose of 15 ml orally on empty stomach for 90 days and Group B will be given Bisphosphonate (as a standard drug)in dose of 70 mg orally once weekly on an empty stomachfor 90days.The record of assessment willbe taken at zero day, 30th day, 60th day and 90th day.